Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Naldemedine on Opioid-induced Bowel Dysfunction. An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled, Cross-over Clinical Trial

NCT06334198 is registered in ClinicalTrials.gov with Asbjørn Mohr Drewes as lead sponsor.

NCT NCT06334198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06334198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Naldemedine on Opioid-induced Bowel Dysfunction. An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled, Cross-over Clinical Trial
Lead sponsor
Asbjørn Mohr Drewes
Phase
Phase 2
Overall status
Unknown status
Start date
March 12, 2024
Completion date
March 31, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation, opioid-induced bowel dysfunction